Compound ID | 1865
Class: Beta-lactam (carbapenem)
Spectrum of activity: | Gram-negative |
Details of activity: | Binds to bacterial penicillin-binding proteins (PBP) and interferes with bacterial cell wall integrity and synthesis. Carbapenems bind to all PBPs, with PBP2 and PBP4 as the highest-affinity targets. Ertapenem is mainly active against Enterobacteriaceae and has a longer half life than othe carbapenems |
Description: | Semisynthetic, derived from thienamycin. Longer half live |
Institute where first reported: | MSD/Merck |
Year first mentioned: | 1992 |
Highest developmental phase: | Approved by FDA in 2001 |
Development status: | Approved, off-patent |
Chemical structure(s): | |
Canonical SMILES: | C[C@@H]1[C@@H]2[C@@H]([C@@H](C)O)C(=O)N2C(=C1S[C@H]3C[C@@H](C(=O)NC4=CC(=CC=C4)C(=O)O)NC3)C(=O)O |
Isomeric SMILES: | C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1S[C@H]3C[C@H](NC3)C(=O)NC4=CC=CC(=C4)C(=O)O)C(=O)O)[C@@H](C)O |
InChI: | InChI=1S/C22H25N3O7S/c1-9-16-15(10(2)26)20(28)25(16)17(22(31)32)18(9)33-13-7-14(23-8-13)19(27)24-12-5-3-4-11(6-12)21(29)30/h3-6,9-10,13-16,23,26H,7-8H2,1-2H3,(H,24,27)(H,29,30)(H,31,32)/t9-,10-,13+,14+,15-,16-/m1/s1 |
InChI Key: | JUZNIMUFDBIJCM-ANEDZVCMSA-N |
Structure link: | https://pubchem.ncbi.nlm.nih.gov/compound/150610 |
External links: | |
Guide to Pharmacology: | ertapenem |
Main Source: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4867097/ |
Citations: |
|